The vaccines are coming. The UK became the first country in the West to approve a covid-19 vaccine for emergency use on December 2, specifically the Pfizer and BioNTech vaccine, which has completed Phase 3 trials. But the US, EU, and many other countries are expected to follow suit in the following days and weeks. The imminent arrival of vaccines not only means that countries face a huge...
The rise of technonationalism. Diverging regulatory regimes. The spread of “walled gardens.” Polarization like nothing we’ve seen before. The confluence of several trends is poised to completely fragment our real and digital worlds. For companies, this raises a host of new risks, from cybersecurity threats to reputation risk—which, in turn, will require new responses and approaches. The...
Miriam was only 21 when she met Nick. She was a photographer, fresh out of college, waiting tables. He was 16 years her senior and a local business owner who had worked in finance. He was charming and charismatic; he took her out on fancy dates and paid for everything. She quickly fell into his orbit. It began with one credit card. At the time, it was the only one she had. Nick would max it out...